Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trial

This publication has 14 references indexed in Scilit:

• Droloxifene, A New Antiestrogen Hormonal Influences in Postmenopausal Breast Cancer Patients
  American Journal of Clinical Oncology, 1991
• Pharmacokinetics of Droloxifene and Its Metabolites in Breast Cancer Patients
  American Journal of Clinical Oncology, 1991
• Mechanism of Action of High-Affinity Antiestrogens An Overview
  American Journal of Clinical Oncology, 1991
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989
• Tamoxifen, serum lipoproteins and cardiovascular risk
  British Journal of Cancer, 1988
• Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens
  Biochemical and Biophysical Research Communications, 1987
• Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours
  British Journal of Cancer, 1987
• Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM)
  The Journal of Steroid Biochemistry and Molecular Biology, 1987
• Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
  Cell, 1987
• In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen
  European Journal of Cancer and Clinical Oncology, 1985